A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer
NCT06181266
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
NMIBC
High Risk NMIBC
Non Muscle Invasive Bladder Cancer
Interventions
DRUG:
ZH9
Sponsor
Prokarium Ltd